PIER 88 INVESTMENT PARTNERS LLC
Position in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 1697366
SAN FRANCISCO, CA
Position in MDGL
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$698,035
+$69,871 QoQ
Shares Held
1,300
+8.3% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.90%
of 13F equity value
Holder Rank
#224
of 411 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PIER 88 INVESTMENT PARTNERS LLC holds $6,341,408 across 13 Biotechnology names. MDGL ranks #3 (11.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KRYS |
Krystal Biotech, Inc.
|
2,400 | $892,008 | |
| 2 | LGND |
Ligand Pharmaceuticals Inc
|
2,600 | $821,834 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
This page
|
1,300 | $698,035 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
8,500 | $665,295 | |
| 5 | ABCL |
AbCellera Biologics Inc.
|
79,900 | $627,215 | |
| 6 | ABSI |
Absci Corp
|
42,500 | $492,575 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
6,300 | $469,224 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
4,100 | $356,495 |
All Filings in MDGL
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $698,035 | 1,300 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $628,164 | 1,200 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $628,927 | 1,080 | Shares | Sole | 2026-02-04 | |
| No filing history on record for this holder in this stock. | ||||||